Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Zydus Lifesciences Limited
Press Release Oct 17 2022
Business
Oct 17 2022
3 min read

Press Release Oct 17 2022

Zydus Lifesciences Limited has informed the Exchange about press release dated 17-Oct-2022 titled 1. Zydus receives tentative approval from the USFDA for Valbenazine Capsules and 2. Zydus receives tentative approval from the USFDA for Roflumilast Tablets

View Attachment